Skip to contentAzelby Robert — JUNO LIGHTING INC insider: 87 transactions · InsiderLensAzelby Robert
- Director at ADURO BIOTECH, INC. · on record since Apr 12, 2023
- Director at CARDINAL HEALTH INC · on record since Mar 18, 2024
- Director at Autolus Therapeutics plc · on record since Mar 18, 2026
- Director at Terns Pharmaceuticals, Inc. · on record since May 5, 2026
- Director at ADC TELECOMMUNICATIONS INC · on record since Jun 3, 2026
- Director at Tango Therapeutics, Inc. · on record since Jun 23, 2026
- EVP & Chief Commercial Officer at JUNO LIGHTING INC · on record since Nov 10, 2016
- Director at CASCADE CORP · on record since Jun 13, 2017
- Director at ALDER BIOPHARMACEUTICALS INC · on record since Jun 15, 2018
- President and CEO at ALDER BIOPHARMACEUTICALS INC · on record since Jun 15, 2018
- Director at Clovis Oncology, Inc. · on record since Oct 15, 2018
- Director at IMMUNOMEDICS INC · on record since Feb 27, 2020
- Director at Climb Bio, Inc. · on record since Aug 9, 2021
- President & CEO at Climb Bio, Inc. · on record since Aug 9, 2021
Insider trading activity of Azelby Robert
- Transactions on record
- 87
- since Nov 2, 2015
- Open-market buys
- 0
- Open-market sells
- 13
- $14.1M
- Companies traded
- 12
- last filing Jul 1, 2026
Figures computed from official regulatory filings — methodology.
Companies where Azelby Robert has traded
- Autolus Therapeutics plc2 tx · Jul 1, 2026
- Tango Therapeutics, Inc.2 tx · Jun 23, 2026
- ADC TELECOMMUNICATIONS INC6 tx · $104.1K · Jun 3, 2026
- Terns Pharmaceuticals, Inc.4 tx · May 5, 2026
- CARDINAL HEALTH INC3 tx · Nov 6, 2025
- ADURO BIOTECH, INC.4 tx · $518.9K · Aug 11, 2023
- Climb Bio, Inc.2 tx · Nov 2, 2022
- Clovis Oncology, Inc.4 tx · Jun 11, 2021
- IMMUNOMEDICS INC5 tx · Oct 23, 2020
- ALDER BIOPHARMACEUTICALS INC
Track record of Azelby Robert
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Azelby Robert
Co-insiders of Azelby Robert
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
8 tx · Oct 24, 2019
MOTT DAVID MCASCADE CORP +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 1, 2026 | AwardD | 31,667 | 0.00 USD | — | SEC |
| Jul 1, 2026 | AwardD | 47,500 | 0.00 USD | — | SEC |
| Jun 23, 2026 | Award | 5,740 | 0.00 USD | — | SEC |
| Jun 23, 2026 | AwardD | 35,910 | 0.00 USD | — | SEC |
| Jun 3, 2026 | Other | -12,600 | 3.08 USD | $38.8K | SEC |
| Jun 3, 2026 | Award | 45,000 | 0.00 USD | $0 | SEC |
| May 5, 2026 | OtherD | -1,697 | — | — | SEC |
| May 5, 2026 | OtherD | -90,000 | — | — | SEC |
| Feb 2, 2026 | AwardD | 1,697 | 0.00 USD | $0 | SEC |
| Nov 6, 2025 | Award | 1,067 | 0.00 USD | $0 | SEC |
| Jun 17, 2025 | Other | -12,600 | 3.58 USD | $45.1K | SEC |
| Jun 5, 2025 | Award | 40,000 | 0.00 USD | $0 | SEC |
| Feb 24, 2025 | AwardD | 90,000 | 0.00 USD | $0 | SEC |
| Nov 7, 2024 | Award | 1,730 | 0.00 USD | $0 | SEC |
| Jun 18, 2024 | Sell | -6,995 | 2.89 USD | $20.2K | SEC |
| Jun 14, 2024 | Award | 40,000 | 0.00 USD | $0 | SEC |
| Mar 18, 2024 | Award | 1,288 | 0.00 USD | $0 | SEC |
| Aug 11, 2023 | OtherD | -7,000 | — | — | SEC |
| Aug 11, 2023 | OtherD | -28,200 | 18.40 USD | $518.9K | SEC |
| Apr 12, 2023 | AwardD | 7,000 | 0.00 USD | $0 | SEC |
| Apr 12, 2023 | AwardD | 28,200 | 0.00 USD | $0 | SEC |
| Nov 2, 2022 | AwardD | 500,000 | 0.00 USD | $0 | SEC |
| Jan 31, 2022 | AwardD | 500,000 | 0.00 USD | $0 | SEC |
| Jun 11, 2021 | AwardD | 42,223 | 0.00 USD | $0 | SEC |
| Oct 23, 2020 | OtherD | -29,040 | — | — | SEC |